40
Views
18
CrossRef citations to date
0
Altmetric
Case Report

Morphea associated with the use of adalimumab: a case report and review of the literature

, , , &
Pages 602-604 | Received 26 Jul 2011, Accepted 28 Sep 2011, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Avery H. LaChance, Nathaniel Goldman, Bina Kassamali & Ruth Ann Vleugels. (2022) Immunologic underpinnings and treatment of morphea. Expert Review of Clinical Immunology 18:5, pages 461-483.
Read now
Yue-Jiao Lan, Napoleon Bellua Sam, Ming-Han Cheng, Hai-Feng Pan & Jian Gao. (2021) Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases. Journal of Inflammation Research 14, pages 6543-6556.
Read now
Hatice Resorlu, Sevilay Kılıc, Selda Isık & Ferhat Gokmen. (2017) Successful infliximab therapy in a patient with comorbid spondyloarthritis, primary biliary cirrhosis and generalized morphea. Acta Clinica Belgica 72:5, pages 365-368.
Read now
Maria Victoria Hernández, Raimon Sanmartí & Juan D. Cañete. (2016) The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis. Expert Opinion on Drug Safety 15:5, pages 613-624.
Read now

Articles from other publishers (14)

Jacob P. Reinhart, Jenna L. Aird, Michael C. Stephens, Sarah Asch, Amir B. Orandi & Megha M. Tollefson. (2022) Tumor necrosis factor‐α inhibitor‐induced morphea and psoriasiform dermatitis in a pediatric patient with Crohn's disease. Pediatric Dermatology 40:3, pages 519-522.
Crossref
Ada Man, M. Kari Connolly & Robert W. Simms. 2022. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology 93 105 .
Giacomo Dal Bello, Paolo Rosina, Chiara Colato & Giampiero Girolomoni. (2020) Nivolumab induced morphea. Giornale Italiano di Dermatologia e Venereologia 155:5.
Crossref
Vicenç Torrente-Segarra, Pedro Campo, Sergi Heredia, Cristina Heras-Mulero & Maria Bonet. (2020) Linear localized morphea associated with golimumab in a patient with spondyloarthritis. Reumatología Clínica (English Edition) 16:4, pages 303-305.
Crossref
Vicenç Torrente-Segarra, Pedro Campo, Sergi Heredia, Cristina Heras-Mulero & Maria Bonet. (2020) Morfea lineal asociada al uso de golimumab en paciente con espondiloartropatía. Reumatología Clínica 16:4, pages 303-305.
Crossref
Leonard C. Sperling, Benjamin Lockshin & Thomas Darling. (2020) Eruptive collagenomas associated with adalimumab treatment of juvenile rheumatoid arthritis. Journal of Cutaneous Pathology 47:3, pages 197-201.
Crossref
Takuya Miyagawa, Yohei Ichimura, Kouki Nakamura, Megumi Hirabayashi, Takashi Yamashita, Ryosuke Saigusa, Shunsuke Miura, Takehiro Takahashi, Tetsuo Toyama, Takashi Taniguchi, Kaname Akamata, Ayumi Yoshizaki, Shinichi Sato & Yoshihide Asano. (2018) Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma. Journal of Dermatological Science 92:2, pages 207-214.
Crossref
Iris M. Otani, Amy S. Levin & Aleena Banerji. (2018) Cutaneous Manifestations of Reactions to Biologics. Current Allergy and Asthma Reports 18:2.
Crossref
Grace W. Kimmel, John K. Nia, Peter W. Hashim & Mark G. Lebwohl. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 295 308 .
Farah Succaria & Jag Bhawan. (2017) Cutaneous side-effects of biologics in immune-mediated disorders: A histopathological perspective. The Journal of Dermatology 44:3, pages 243-250.
Crossref
Irina Khamaganova. (2017) Localized Scleroderma: Predisposing and Triggering Factors. The Open Dermatology Journal 11:1, pages 1-11.
Crossref
Suzanne C. Li & Elena Pope. 2016. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology 406 417.e4 .
Spencer A. Bezalel, Bruce E. Strober & Katalin Ferenczi. (2015) Interferon beta-1a–induced morphea. JAAD Case Reports 1:1, pages 15-17.
Crossref
Brian A. Baldo. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 561 590 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.